J7315 Mitomycin, ophthalmic, 0.2 mg
Billable / valid for submission HCPCS Release 2026Q3
Short description: Ophthalmic mitomycin
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| 2026Q3 | 2026-07-01 | current | Mitomycin, ophthalmic, 0.2 mg | yes |
Related codes in J73
- J7300 Intrauterine copper contraceptive (paragard)
- J7301 Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg
- J7304 Contraceptive supply, hormone containing patch, each
- J7306 Levonorgestrel (contraceptive) implant system, including implants and supplies
- J7307 Etonogestrel (contraceptive) implant system, including implant and supplies
- J7308 Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)
- J7311 Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg
- J7312 Injection, dexamethasone, intravitreal implant, 0.1 mg
- J7313 Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg
- J7314 Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg
- J7316 Injection, ocriplasmin, 0.125 mg
- J7318 Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg
- J7320 Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg
- J7321 Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose
- J7322 Hyaluronan or derivative, hymovis or hymovis one, for intra-articular injection, 1 mg
- J7323 Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose
- J7324 Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose
- J7325 Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg
- J7326 Hyaluronan or derivative, gel-one, for intra-articular injection, per dose
- J7327 Hyaluronan or derivative, monovisc, for intra-articular injection, per dose